GLP1R and psoriasis: Xu et al. [4] report that after a weeks-long procedure of treatment with the glucagon-like peptide (GLP)-1 analog (liraglutide), levels of LDL-C and the psoriasis area and severity index (PASI) were much reduced in PsO [4].